Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of a Multiple Biomarker Assay to Estimate the Risk of Ovarian Cancer in Patients Presenting With a Pelvic Mass.

NCT00315692 is registered in ClinicalTrials.gov with Fujirebio Diagnostics, Inc. as lead sponsor.

NCT NCT00315692
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00315692 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of a Multiple Biomarker Assay to Estimate the Risk of Ovarian Cancer in Patients Presenting With a Pelvic Mass.
Lead sponsor
Fujirebio Diagnostics, Inc.
Phase
Observational
Overall status
Completed
Start date
December 31, 2005
Completion date
February 28, 2007
Enrollment
566 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer